Insight

Why rates of radiation pneumonitis are high over time with raising use of immunotherapy – MSK Radiation Oncology

Photo of Narek Shaverdian taken from www.mskcc.org

Mar 29, 2024, 06:08

Why rates of radiation pneumonitis are high over time with raising use of immunotherapy – MSK Radiation Oncology

Memorial Sloan Kettering Radiation Oncology shared on X/Twitter:

“Dr. Narek Shaverdian presents at our ‘Work in Progress’ thoracic radiation oncology meeting at Memorial Sloan Kettering Cancer Center on why rates of radiation pneumonitis are high over time with raising use of immunotherapy and why it is an important target for intervention to improve lung cancer outcomes.”

Why rates of radiation pneumonitis are high over time with raising use of immunotherapy - MSK Radiation Oncology

Source: Memorial Sloan Kettering Radiation Oncology/X

cancer immunotherapy Lung cancer Memorial Sloan Kettering Cancer Center Memorial Sloan Kettering Radiation Oncology MSK Narek Shaverdian OncoDaily Oncology radiation oncology radiation pneumonitis thoracic radiation oncology Work in Progress

In Memory of Alan Rickman and His Battle with Prostate and Pancreatic Cancer

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC

Oncologist Near Me – Nazik Hammad: A Leader in Cancer Care, Medical Education, and Health Equity

Garo Armen - A Bold Call to Action: Embracing Real-Time Innovation in Pediatric Cancer